What does PRISM BioLab Co.,LTD do?
PRISM BioLab Co.,LTD engages in the research and development of pharmaceuticals using its proprietary drug discovery platform technology, PepMetics Technology. It develops E7386 targeting CBP/beta-catenin, which is in Phase II clinical trial for the treatment of cancer; and PRI724 targeting CBP/beta-catenin that is…
What is PRISM BioLab Co.,LTD's P/E and P/B ratio?
PRISM BioLab Co.,LTD has a P/E ratio of -5.6 and a P/B ratio of 2.64.
What is PRISM BioLab Co.,LTD's debt-to-equity ratio?
PRISM BioLab Co.,LTD has a debt-to-equity ratio of 0.00.
How much does PRISM BioLab Co.,LTD owe compared with what it owns?
PRISM BioLab Co.,LTD owes ¥0.24 for every ¥1 it owns (balance sheet Jun 2026), which is low.
What is PRISM BioLab Co.,LTD's Positivity rank?
PRISM BioLab Co.,LTD is ranked #6,061 of 10,750 companies globally and #2,853 of 3,683 in Japan on PositoAI, with a Positivity Score of 20,994.
Does PRISM BioLab Co.,LTD have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for PRISM BioLab Co.,LTD.
Where can I read the latest news about PRISM BioLab Co.,LTD?
Recent headlines about PRISM BioLab Co.,LTD from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does PRISM BioLab Co.,LTD have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of PRISM BioLab Co.,LTD's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.